Incident hypertension in older women and men with or at risk for HIV infection

HIV Medicine

Volumn 14, Issue 6, 2013, Pages 337-346

  Factor, S H ^a   Lo, Y ^a,b   Schoenbaum, E ^b   Klein, R S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Antiretroviral therapy; CD4 T cells; HIV infection; Hypertension; Immunity; Perimenopause

Indexed keywords

CHOLESTEROL;

ADULT; ALCOHOLISM; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CHOLESTEROL BLOOD LEVEL; CLIMACTERIUM; COHORT ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS; DRUG USE; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INCIDENCE; INTERVIEW; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MENOPAUSE; NEGRO; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; SEXUAL BEHAVIOR; SMOKING;

ADULT; CLINICAL LABORATORY TECHNIQUES; CLINICAL MEDICINE; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; HYPERTENSION; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; RISK ASSESSMENT;

EID: 84878901838     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/hiv.12010     Document Type: Article

References (33)

1. UNAIDS. UNAIDS Outlook report 2010. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS). Available at www.unaids.org/outlook/OutlookReport.
2. Palella FJ, Jr, Delaney KM, Moorman AC etal. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338: 853-860.
3. Adih WK, Selik RM, Xiaohong H. Trends in diseases reported on US death certificates that mentioned HIV infection, 1996-2006. J Int Assoc Physicians AIDS Care (Chic) 2011; 10: 5-11.
4. Seligman SJ, Gross D. Trends in infectious disease and cancer in HIV infection. Ann Intern Med 1996; 125: 777.
5. Dube MP, Lipshultz SE, Fichtenbaum CJ, Greenberg R, Schecter AD, Fisher SD. Effects of HIV infection and antiretroviral therapy on the heart and vasculature. Circulation 2008; 118: e36-e40.
6. Giannarelli C, Klein RS, Badimon JJ. Cardiovascular implications of HIV-induced dyslipidemia. Atherosclerosis 2010; 219: 384-389.
7. Mangili A, Polak JF, Quach LA, Gerrior J, Wanke CA. Markers of atherosclerosis and inflammation and mortality in patients with HIV infection. Atherosclerosis 2011; 214: 468-473.
8. Lai S, Lai H, Celentano DD etal. Factors associated with accelerated atherosclerosis in HIV-1-infected persons treated with protease inhibitors. AIDS patient care and STDs 2003; 17: 211-219.
9. Carpentier A, Patterson BW, Uffelman KD, Salit I, Lewis GF. Mechanism of highly active anti-retroviral therapy-induced hyperlipidemia in HIV-infected individuals. Atherosclerosis 2005; 178: 165-172.
10. Asztalos BF, Schaefer EJ, Horvath KV etal. Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients. Atherosclerosis 2006; 184: 72-77.
11. de Saint Martin L, Vandhuick O, Guillo P etal. Premature atherosclerosis in HIV positive patients and cumulated time of exposure to antiretroviral therapy (SHIVA study). Atherosclerosis 2006; 185: 361-367.
12. Duprez DA, Kuller LH, Tracy R etal. Lipoprotein particle subclasses, cardiovascular disease and HIV infection. Atherosclerosis 2009; 207: 524-529.
13. Baekken M, Os I, Sandvik L, Oektedalen O. Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy. J Hypertens 2008; 26: 2126-2133.
14. Jerico C, Knobel H, Montero M etal. Hypertension in HIV-infected patients: prevalence and related factors. Am J Hypertens 2005; 18: 1396-1401.
15. Seaberg EC, Munoz A, Lu M etal. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 2005; 19: 953-960.
16. Miller SA, Santoro N, Lo Y etal. Menopause symptoms in HIV-infected and drug-using women. Menopause 2005; 12: 348-356.
17. Klein RS, Lo Y, Santoro N, Dobs AS. Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis 2005; 41: 1794-1803.
18. Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry 1974; 131: 1121-1123.
19. Dhalla S, Kopec JA. The CAGE questionnaire for alcohol misuse: a review of reliability and validity studies. Clin Invest Med 2007; 30: 33-41.
20. Khalsa A, Karim R, Mack WJ etal. Correlates of prevalent hypertension in a large cohort of HIV-infected women: women's Interagency HIV Study. AIDS 2007; 21: 2539-2541.
21. Herrera J, Ferrebuz A, MacGregor EG, Rodriguez-Iturbe B. Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis. J Am Soc Nephrol 2006; 17 (Suppl 3): S218-S225.
22. Svendsen UG. Evidence for an initial, thymus independent and a chronic, thymus dependent phase of DOCA and salt hypertension in mice. Acta Pathol Microbiol Scand 1976; 84: 523-528.
23. Guzik TJ, Hoch NE, Brown KA etal. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007; 204: 2449-2460.
24. Madhur MS, Lob HE, McCann LA etal. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 2010; 55: 500-507.
25. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 2009; 78: 539-552.
26. Pedersen BK. Exercise-induced myokines and their role in chronic diseases. Brain Behav Immun 2011; 25: 811-816.
27. Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 2008; 214: 231-241.
28. Sandler NG, Wand H, Roque A etal. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 2011; 203: 780-790.
29. Kuller LH, Tracy R, Belloso W etal. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008; 5: e203.
30. Tien PC, Choi AI, Zolopa AR etal. Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort. J Acquir Immune Defic Syndr 2010; 55: 316-322.
31. Neuhaus J, Jacobs DR, Jr, Baker JV etal. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 2010; 201: 1788-1795.
32. Kaplan RC, Sinclair E, Landay AL etal. T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis 2011; 203: 452-463.
33. Lyons JL, Uno H, Ancuta P etal. Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection. J Acquir Immune Defic Syndr 2011; 57: 371-379.